Loading…
melanoma
malignant neoplasm originating from melanocytes
Details
- Instance of
- rare disease, type of disease
- Subclass of
- skin cancer, cell type cancer
- described by source
- Great Soviet Encyclopedia (1926–1947), Armenian Soviet Encyclopedia, vol. 7
- drug or therapy used for treatment
- dactinomycin, bleomycin, docetaxel, temozolomide, dacarbazine, aldesleukin, procarbazine, lomustine, hydroxycarbamide, dabrafenib, pembrolizumab, vemurafenib
- genetic association
- DOCK3, TET2, EYS, FTO, ATM, MX2, SLC45A2, monophenol monooxygenase, PLA2G6, PARP1, ANXA9, CDKN2A
- health specialty
- oncology
- ICPC 2 ID
- S77
- topic's main category
- Category:Melanoma
Connected on Wikidata
Subject of
- Not as a Stranger
- Melanoma Research
- Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy Following Cyclophosphamide And Fludarabine In Patients With Melanoma
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
- Surgery for Gastrointestinal Metastases of Malignant Melanoma - a Single Center Retrospective Cohort Study
- Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain
- Dabrafenib and/or Trametinib Rollover Study
- A Study of PLX2853 in Advanced Malignancies.
- A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)
- Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease
- MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers
Nothing in the MetaHistoryBook collection references this item yet.